MIDI enters the New Year expanding its rapid prototyping capabilities to better serve its clients’ needs when performing Medical Device Development Services under its DevelopmentDNA™, ISO-13485 compliant, device development approach. This will allow the MIDI Team to respond with enhanced capabilities/speed, under AGILE Development Sprints for its clientele in 2022.

This week a second SLA printer and second FDM printer are being onboarded within MIDI’s prototype lab. Both are the latest generation supporting large build volumes. See the new printers below.

Formlabs; Form 3L SLA Printer, Form Cure L, Form Wash L, Build Volume, 13 x 8 x 12

Stratasys; F370 FDM Printer, Build Volume, 14 x 10 x 14

The increase in printing capacity and larger build volumes will allow MIDI’s AGILE Development Sprints to be deployed with enhanced briskness. We look forward to continuing to serve your medical device development needs with our enhanced capabilities in 2022 and beyond.